在质母细胞瘤中结合先天性和适应性免疫力;一个α-CTLA-4探索

Nicolas Camviel1, Leila Akkari1

  • 1Division of Tumour Biology and Immunology, Oncode Institute, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.

Trends in immunology
|November 10, 2023
PubMed
概括

质母细胞瘤免疫疗法在小鼠中的α-CTLA-4抗体 (Ab) 显示出前景. 这种治疗激活了CD4+ Th1 T细胞和微质细胞,从而产生强烈的抗瘤反应,对抗类似间细胞母细胞瘤.